CClinicalTrials.gg
Status unknownNCT01602094Updated May 18, 2012

Immunity to Measles Virus in the Thai Population Age 18-30 Years and Predictive Factors

An observational study in Measles, sponsored by Queen Saovabha Memorial Institute. Status unknown at 1 site in Thailand. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-05-18.

Sponsored by Queen Saovabha Memorial Institute · Observational

The sponsor has not verified this record recently (last verified May 2012), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
550
Ages
18 Years to 30 Years
Sex
All
01

Study summary

Prevalence of participants who have protective immunity to measles virus is less than ninety percent.

Predictor of adequate measles antibody levels include the following :

  • History of measles infection
  • History of complete measles primary immunization( 2 doses with at least 1 month interval after age of 9 months)
  • History of measles exposure

Predictor of inadequate measles antibody levels include the following :

  • Born outside Thailand
  • History of staying outside Thailand for long time in childhood
  • Living in the rural area for a long period in childhood
  • Fail to participate school system on time
02

Conditions studied

  • Measles

Browse trials for

Keywords

  • measles
  • antibody
  • prevalence
  • predictors
  • Donor of National Blood Centre, The Thai Red Cross Society who age 18-30 years old
  • Measles antibody levels
  • Predictors of adequate measles antibody levels and inadequate measles antibody levels
03

In context

Measles

120 studies on the registry are indexed under Measles; 17 are open to participants now.

This study's planned enrollment of 550 is above the median of 277 across 24 observational studies indexed under Measles.

Browse Measles studies →

Lead sponsor

Queen Saovabha Memorial Institute is the lead sponsor of 12 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Health Thai participant age 18-30 years old.

Inclusion criteria

  • Age 18-30 years old

Exclusion criteria

Exclusion Criteria:

  • Last measles vaccination less than 10 years of age
  • Immunocompromised host including congenital immune defect, splenectomy or splenic dysfunction, history of suspect HIV exposure, taking immunosuppressant
  • Receiving blood or blood product within 3 months
  • Receiving others vaccinations or immunoglobulins or any medication that possibly decrease immune response
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
550 participants (estimated)
Biospecimen retention
Samples without dna

Groups and cohorts

  • Adequate antimeales antibody levels

    ELISA test OD \> 0.1

  • Inadequate measles antibody levels

    ELISA test OD \< 0.1

06

Study locations

1 site
  • Queen Saovabha Memorial Institute
    Bangkok, 10330, Thailand
    • Maneerat Benjavongkulchai, R.N. · Contact · neowmanee@yahoo.com · 662-252-0161-4
    • Jaruboot Angsanakul, M.D. · Principal investigator
    • Maneerat Benjavongkulchai, R.N. · Sub investigator
07

References and documents

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 18, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01602094
Lead sponsor
Queen Saovabha Memorial Institute
Responsible party
Jaruboot Angsanakul (Jaruboot Angsanakul, Queen Saovabha Memorial Institute) — Principal investigator
First posted
May 18, 2012
Start date
Jul 2012
Primary completion
Jan 2013 (estimated)
Completion
Mar 2013 (estimated)
Last update
May 18, 2012

Study contacts

Jaruboot Angsanakul, M.D.
Contact
jaruboot@yahoo.com
662-252-0161-4 ext. 132
Jaruboot Angsanakul, M.D.
principal investigator · Queen Saovabha Memorial Institute

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion